Intellia Therapeutics, INC. (NTLA) — SC 13G/A Filings

All SC 13G/A filings from Intellia Therapeutics, INC.. Browse 4 SC 13G/A reports with AI-powered summaries and risk analysis.

SC 13G/A Filings (4)

SC 13G/A Filing — Feb 13, 2024
ARK Investment Management Holds 12.9% Stake in Intellia Therapeutics — Jan 29, 2024
ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on January 29, 2024, revealing a significant stake in Intellia Therapeutics, Inc. A
State Street Corp. Updates Passive Stake in Intellia Therapeutics — Jan 24, 2024
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 24, 2024, indicating its ownership of Intellia Therapeutics Inc. c
BlackRock Amends Intellia Therapeutics Stake, Signals Confidence — Jan 8, 2024
BlackRock, Inc. filed an amended SC 13G/A on January 8, 2024, indicating its ownership of Intellia Therapeutics, Inc. Common Stock as of December 31, 2023. This

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX